مقالات مجله بین المللی سیاست و مدیریت بهداشت، دوره 13، شماره 1
6.Institutional Priority-Setting for Novel Drugs and Therapeutics: A Qualitative Systematic Review FullText
12.The Adaptation of Digital Health Solutions During the COVID-۱۹ Pandemic in Hungary: A Scoping Review FullText
14.Phase IV Drug Trials With a Canadian Site: A Comparison of Industry-Funded and Non-IndustryFunded Trials FullText
17.Policy Actors’ Perceptions of Conflicts of Interest and Alcohol Industry Engagement in UK Policy Processes FullText
20.Inhibitors and Supporters of Policy Change in the Regulation of Unhealthy Food Marketing in Australia FullText
22.Unravelling Low-Value Care Decision-Making: Residents’ Perspectives on the Influence of Contextual Factors FullText
28.Association of Launch Price and Clinical Value With Reimbursement Decisions for Anticancer Drugs in China FullText
37.Exploring the County Level Mortality Pattern Variations in Rural Areas of Iran (۲۰۰۶-۲۰۱۶) FullText
41.Achieving Diagnostic Excellence: Roadmaps to Develop and Use Patient-Reported Measures With an Equity Lens FullText
44.Negative Emotions Are Associated With Older Self-perceived Age: A Cross-section Study From the UK Biobank FullText
49.Decentralisation of the Health System Derailed by Organisational Inertia in Machinga, Malawi FullText
57.Quality Measurement in Shanghai From a Global Perspective; A Response to Recent Commentaries FullText
تاریخ نمایه سازی مقالات: 17 مرداد 1403 - تعداد نمایش اطلاعات ژورنال: 53